Vaccine News and Research

Latest Vaccine News and Research

Thrombosis with thrombocytopenia syndrome rare but serious adverse event associated with Ad26.COV2.S vaccination

A recent study conducted in the United States has revealed that thrombosis with thrombocytopenia syndrome following adenoviral vector-based coronavirus disease 2019 (COVID-19) vaccination is a rare event.

16 Nov 2021

Deficient spike-specific T cell responses and inability to neutralize SARS-CoV-2 variants 12 month post-infection

Researchers conducted a comprehensive, longitudinal, long-term immune study, including functional assays to assess immune fitness against antigenically different VoC. The study is currently available on the preprint server medRxiv* while awaiting peer review.

15 Nov 2021

Immune response elicited by SARS-CoV-2 vaccines in infliximab and vedolizumab-treated patients with IBD

A recent study evaluates the immune responses elicited by COVID-19 vaccines in infliximab- or vedolizumab-treated IBD patients.

15 Nov 2021

Study identifies a host factor that reflects different levels of inflammation within mild COVID-19 cases

A new study investigates serum from COVID-19 convalescents and uninfected individuals to determine the molecular mechanisms of host responses.

15 Nov 2021

Scientists develop a promising new approach to potentially treat Alzheimer's disease

A promising new approach to potentially treat Alzheimer's disease – and also vaccinate against it – has been developed by a team of UK and German scientists.

15 Nov 2021

Promising results from Phase II REGEN-COV study

Initial results of the REGEN-COV Phase II study are presented.

15 Nov 2021

Potential COVID-19 nasal spray vaccine shows promise in mice

A single sniff may one day be all it takes to immunize yourself against COVID-19.

15 Nov 2021

Long-term study begins to evaluate COVID-19's effects on the overall health of children

A large, long-term study of the impacts of COVID-19 on children has enrolled its first participant at the National Institutes of Health's Clinical Center in Bethesda, Maryland.

15 Nov 2021

Three doses of COVID-19 mRNA vaccination safe in high-risk populations

A new study determines the safety of an additional vaccine among individuals who previously received two doses of mRNA-based COVID-19 vaccines.

15 Nov 2021

Benefits of vaccine mandates and vaccine passports for SARS-CoV-2

A new study has been published that evaluates the benefits of VMVP by estimating the benefits of vaccination and exclusion of unvaccinated people from different settings.

15 Nov 2021

Vaccination protects against COVID-19 related hospitalization in patients with and without comorbidity

Researchers from University Medical Centre Utrecht have been investigating the efficiency of vaccines against the alpha variant in the Netherlands.

15 Nov 2021

Mainstream media coverage of vaccines during COVID-19 pandemic

A recent study explores how vaccine coverage has come to the forefront of modern news media following the emergence of SARS-CoV-2.

15 Nov 2021

Public health strategies associated with reduced SARS-CoV-2 transmission in Switzerland

The current study attempts to estimate the quantitative effects of specific measures, using a combination of phylogenetic and phylodynamic approaches.

15 Nov 2021

Vaccination model for endemic COVID-19

The current model is meant to provide an understanding of what might happen in the future, with periods of very low infection prevalence, interspersed between surges that have ever-lower peaks.

15 Nov 2021

Study finds COVID vaccination rates differ by occupation

While COVID-19 vaccines are available to all adults in England, new research suggests a disproportionate number of people who have not gotten the vaccine work in public-facing jobs. In addition, people who work from home were more likely to be vaccinated, suggesting ‘work from policies’ are limited in their effectiveness in preventing hospitalizations and COVID-19 deaths.

14 Nov 2021

Research on SARS-CoV-2 breakthrough infections shows the danger posed by Delta

Scientists from Florida, USA, have conducted a study to determine the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission from individuals with delta breakthrough infections. The findings reveal that delta breakthrough cases exhibit a relatively lower viral load compared to unvaccinated cases.

14 Nov 2021

Vaccine News and Research

Latest Vaccine News and Research

Thrombosis with thrombocytopenia syndrome rare but serious adverse event associated with Ad26.COV2.S vaccination

Deficient spike-specific T cell responses and inability to neutralize SARS-CoV-2 variants 12 month post-infection

Immune response elicited by SARS-CoV-2 vaccines in infliximab and vedolizumab-treated patients with IBD

Study identifies a host factor that reflects different levels of inflammation within mild COVID-19 cases

Scientists develop a promising new approach to potentially treat Alzheimer's disease

Promising results from Phase II REGEN-COV study

Potential COVID-19 nasal spray vaccine shows promise in mice

Long-term study begins to evaluate COVID-19's effects on the overall health of children

Three doses of COVID-19 mRNA vaccination safe in high-risk populations

Benefits of vaccine mandates and vaccine passports for SARS-CoV-2

Vaccination protects against COVID-19 related hospitalization in patients with and without comorbidity

Mainstream media coverage of vaccines during COVID-19 pandemic

Public health strategies associated with reduced SARS-CoV-2 transmission in Switzerland

Vaccination model for endemic COVID-19

Study finds COVID vaccination rates differ by occupation

Research on SARS-CoV-2 breakthrough infections shows the danger posed by Delta

The case for vaccinating children under 12 against COVID-19

Can COVID-19 vaccination lead to neurological complications?

Increased risk of breakthrough SARS-CoV-2 infection with ChAdOx1 compared to BNT162b2 vaccine

Partial resistance to neutralizing antibodies and enhanced transmissibility of SARS-CoV-2 Delta variant

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: The 5th mRNA-Based Therapeutics Summit Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in